The largest database of trusted experimental protocols

25 protocols using fluoroskan ascent microplate reader

1

Fluorescent Protein Labeling and Characterization

Check if the same lab product or an alternative is used in the 5 most similar protocols
Different proteins were labeled with biotin (Biotin N-hydroxysuccinimide ester, BNHS, Sigma) and ANXV was labeled with the fluorescein (6-[Fluorescein-5(6)-carboxamido] hexanoic acid N-hydroxysuccinimide ester, FNHS, λex: 490 nm/λem: 514 nm, Sigma), using standard procedure for amine coupling provided by the manufacturer's instructions. The fluorescence, expressed as a relative fluorescent unit (RFU), of the two sfGFP derivatives was monitored by measuring it at different pairs of wavelengths for excitation (λex) and emission (λem) using Fluoroskan Ascent® microplate reader (Thermo Labsystems), and the free fluorophore FNHS was used as a control.
+ Open protocol
+ Expand
2

HDAC Inhibition Assay: Screening Compounds

Check if the same lab product or an alternative is used in the 5 most similar protocols
The in vitro inhibitory activity of 1a, 1g, 1l, 1q, 1u, 1v and SAHA against two human HDAC isoforms (1 and 6) were measured using a previously published protocol [55 (link)]. OptiPlate-96 black microplates (Perkin Elmer) were used with an assay volume of 50 µ L. 5 µ L test compound or control, diluted in assay buffer (50 mM Tris-HCl, pH 8.0, 137 mM NaCl, 2.7 mM KCl, 1 mM MgCl2, 0.1 mg/mL BSA), were incubated with 35 µ L of the fluorogenic substrate ZMAL (Z- (Ac)Lys-AMC) [56 (link)] (21.43 µM in assay buffer) and 10 µ L of human recombinant HDAC1 (BPS Bioscience, Catalog# 50051) or HDAC6 (BPS Bioscience, Catalog# 50006) at 37 °C. After an incubation time of 90 min, 50 µ L of 0.4 mg/mL trypsin in trypsin buffer (50 mM Tris-HCl, pH 8.0, 100 mM NaCl) were added, followed by further incubation at 37 °C for 30 min. Fluorescence was measured with an excitation wavelength of 355 nm and an emission wavelength of 460 nm using a Fluoroskan Ascent microplate reader (Thermo Scientific). All compounds were evaluated in duplicate in at least two independent experiments.
+ Open protocol
+ Expand
3

HDAC Inhibitory Activity Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
The in vitro inhibitory activities (IC50 values) of compounds 1, 2, and 4 (Bavarostat) against HDAC isozymes have been previously reported.30 ,31 (link) The in vitro inhibitory activities of compound 3 against HDAC6 and HDAC1 were measured using a previously described protocol.35 (link) OptiPlate-96 black microplates (Perkin Elmer) were used with an assay volume of 50 μL. A total of 5 μL 3 or control, diluted in assay buffer [50 mM Tris-HCl (pH 8.0), 137 mM NaCl, 2.7 mM KCl, 1 mM MgCl2, 0.1 mg/mL BSA], were incubated with 35 μL of the fluorogenic substrate ZMAL (ZLys(Ac)-AMC)36 (link) (21.43 μM in assay buffer) and 10 μL of human recombinant HDAC1 (BPS Bioscience, Catalog #50051) or HDAC6 (BPS Bioscience, Catalog #50006) at 37 °C. After an incubation time of 90 min, 50 μL of 0.4 mg/mL trypsin in trypsin buffer [50 mM Tris-HCl (pH 8.0), 100 mM NaCl] were added, followed by further incubation at 37 °C for 30 min. Fluorescence was measured with an excitation wavelength of 355 nm and an emission wavelength of 460 nm using a Fluoroskan Ascent microplate reader (Thermo Scientific). Compound 3 was evaluated in duplicate in two independent experiments.
+ Open protocol
+ Expand
4

Evaluating Antioxidant Capacity by ORAC Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
The oxygen radical absorbance capacity (ORAC) assay was performed to assess the antioxidant capacity of MEs, using Trolox as a positive control [26 (link)]. Briefly, 25 μL of MEs or Trolox were pipetted in a 96-well white microplate (with clear bottom), whereas phosphate buffer (25 μL, 75 mM, pH 7.4) was transferred in the negative control wells. Fluorescein solution (150 μL, 25 nM) was added in each well and the plate was incubated in the dark at 37 °C for 30 min. Subsequently, AAPH solution (25 μL, 0.15 M) was added in the positive control and the antioxidant wells, whereas phosphate buffer (25 μL) was pipetted in the negative control, and the fluorescence was measured every 2 min over a period of 2 h (485/20 nm excitation, 525/20 nm emission) using a Fluoroskan Ascent microplate reader (ThermoScientific, Waltham, MA, USA). The non-enzymatic DHA oxidation that occurred in the microemulsions was measured as described below (Section 2.4.4).
+ Open protocol
+ Expand
5

Screening for Potent Drug Inhibitors

Check if the same lab product or an alternative is used in the 5 most similar protocols
A drug library comprising 1,165 off-patent drugs was used for identifying inhibitors of the candidate compounds with higher effectiveness than MMC. The mTCFs were placed onto 96-well plates (3,000 cells/mm2) with a Multidrop Combi (Thermo Fisher Scientific, USA) and incubated at 37 °C overnight. They were then treated with DMEM containing the candidate drugs at a final concentration of 10 μM. Twenty-four hours later, the cells were incubated in DMEM containing 10% Alamar Blue reagent (Life Technologies Inc., USA) at 37 °C for 2 h in the dark. Fluorescence intensity was measured at 544 nm excitation and 590 nm emission with a Fluoroskan Ascent microplate reader (Thermo Fisher Scientific, USA).
For the evaluation of corneal cytotoxicity, the human corneal epithelial cells were placed onto 96-well plates at 2,000 cells/mm2 and treated with 10 μM mTCF-growth suppressive drugs in CnT-20 medium at 37 °C for 24 h. All following procedures were then performed as above.
+ Open protocol
+ Expand
6

Thrombin Generation Assay with Plasma

Check if the same lab product or an alternative is used in the 5 most similar protocols
PRP or plasma was diluted 1:1 with FV-deficient plasma. For plasma experiments, plasma (40μL) was incubated (10min, 37°C) with an activation mixture (10μL) containing FXa or TF (varying concentrations) and PC:PE:PS (4μM final) in 20mM HEPES, 150mM NaCl, 0.1% bovine serum albumin, pH 7.4 (HBSA). For PRP experiments, the activation mixture contained FXa (varying concentrations) and collagen (20μg/mL final) in HBSA. For some experiments, anti-K1 (50nM), anti-K2 (50nM), anti-K3C (50nM), LIKTKRKRKK (1μM), TFPIα (1nM), APC (5nM), and/or HAPC1555 (50nM) was included in the incubation. Thrombin generation was initiated with a mixture of calcium and thrombin fluorogenic substrate (FluCa; Diagnostica Stago) (10μL). Fluorescence was monitored on a Fluoroskan Ascent microplate reader (Thermo Scientific), and thrombin calculated with Thrombinoscope v5 software (Thrombinoscope BV). All samples were measured in triplicate.
+ Open protocol
+ Expand
7

Measuring Intracellular ROS Levels

Check if the same lab product or an alternative is used in the 5 most similar protocols
The intracellular reactive oxygen species (ROS) level was measured using a membrane-permeant H2DCFDA fluorogenic probe, as described previously.13 (link) Briefly, 1 × 105 cells were seeded in a 12-well plate and allowed to attach overnight. The cells were pretreated with various concentrations of UDE (1–30 μg/mL) for 1 hour and then stimulated with 15 ng/mL of TNF-α for 3 hours. Subsequently, the cells were stained with 5 μM H2DCFDA for 30 minutes at 37 °C. The cells were collected, and fluorescence was measured using a Fluoroskan Ascent microplate reader (Thermo Scientific) at wavelengths of 485 nm for excitation and 530 nm for emission.
+ Open protocol
+ Expand
8

Optimized RT-QuIC Assay for α-Synuclein Aggregates

Check if the same lab product or an alternative is used in the 5 most similar protocols
The solution containing in vitro generated α-synuclein aggregates was sonicated for 3 min at 500 W and serially diluted (from 10− 1 to 10− 12 volume/volume) in its own reaction buffer. Five μL of the following dilutions: undiluted, 10− 3, 10− 6, 10− 9, 10− 12 was added to 95 μL of reaction mix and subjected to RT-QuIC analysis. Reaction mix was composed as follow: rec-αS diluted in 40 mM PBS (pH 8.0), 170 mM NaCl and 10 μM Thioflavin-T (ThT) at the final concentration of 140 μM. All reagents used for the preparation of the reaction mix were filtered through a 0.22 μm filter before the addition of α-synuclein aggregates. All RT-QuIC reactions were performed in triplicate in a black 96-well optical flat bottom plate (Thermo Scientific) using the Fluoroskan Ascent microplate reader (Thermo Scientific). Samples underwent to cycles of shaking (1 min at 600 rpm, single orbital) and incubation (14 min at 42 °C). Fluorescent intensities, expressed as arbitrary units (AU), were taken every 30 min using 450 ± 10 nm (excitation) and 480 ± 10 nm (emission) wave-lengths, with a bottom read. The addition of a 3-mm glass bead (Sigma) was necessary to sustain protein aggregation.
+ Open protocol
+ Expand
9

HDAC Inhibition Activity Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
The in vitro inhibitory activity of compounds 1-3 and vorinostat against human HDAC1, HDAC2, HDAC3/NcoR2 and HDAC6 were measured using a previously published protocol.44 OptiPlate-96 black microplates (Perkin Elmer) were used with an assay volume of 50 μL. 5.0 μL test compound or control, diluted in assay buffer (50 mM Tris-HCl, pH 8.0, 137 mM NaCl, 2.7 mM KCl, 1.0 mM MgCl2, 0.1 mg/mL BSA), were incubated with 35 μL of the fluorogenic substrate ZMAL (Z-Lys(Ac)-AMC)45 (link) (21.43 μM in assay buffer) and 10 μL of human recombinant HDAC1 (BPS Bioscience, Catalog# 50051), HDAC2 (BPS Bioscience, Catalog# 50052), HDAC3/NcoR2 (BPS Bioscience, Catalog# 50003) or HDAC6 (BPS Bioscience, Catalog# 50006) at 37 °C. After an incubation time of 90 min, 50 μL of 0.4 mg/mL trypsin in trypsin buffer (50 mM Tris-HCl, pH 8.0, 100 mM NaCl) were added, followed by further incubation at 37 °C for 30 min. Fluorescence was measured with an excitation wavelength of 355 nm and an emission wavelength of 460 nm using a Fluoroskan Ascent microplate reader (Thermo Scientific). All compounds were evaluated in duplicate in at least two independent experiments.
+ Open protocol
+ Expand
10

Thioflavin-T Assay for Protein Aggregation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Rec-αS was diluted in a reaction mix composed of 40 mM PBS (pH 8.0), 170 mM NaCl and 10 μM Thioflavin-T (ThT) at the final concentration of 140 μM. Reactions were performed in triplicate in a black 96-well optical flat bottom plate (Thermo Scientific). Each well was supplemented with 100 μL of reaction mix. The plate was sealed with a sealing film (Thermo Scientific), inserted into a Fluoroskan Ascent microplate reader (Thermo Scientific) and subjected to cycles of shaking (1 min at 600 rpm, single orbital) and incubation (14 min at 42 °C). The addition of a 3-mm glass bead (Sigma) was required to sustain protein aggregation. The presence of protein aggregates was confirmed by means of ThT analysis, Western blot and Transmission Electron Microscopy (TEM) analyses.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!